PT-141 vs Tesamorelin

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

PT-141 is primarily a hormonal peptide, while Tesamorelin is used for performance & growth.

This page compares PT-141 and Tesamorelin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

PT-141Tesamorelin
CategoryHormonalPerformance & Growth
Regulatory status (US)FDA approvedFDA approved
Typical dosage1.75 mg2 mg
Frequencyas neededdaily
Reported benefitsEnhanced libido, improved sexual function, arousal supportVisceral fat reduction, improved body composition, GH release
Reported side effectsNausea, flushing, blood pressure changesJoint pain, peripheral edema

Key differences

Primary use. PT-141 is categorised under Hormonal, while Tesamorelin falls under Performance & Growth. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. PT-141: FDA-approved. Tesamorelin: FDA-approved.

Dosing. PT-141 is typically dosed at 1.75 mg (as needed). Tesamorelin is typically dosed at 2 mg (daily).

Can you stack them?

Some protocols combine peptides, but stacking PT-141 and Tesamorelin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between PT-141 and Tesamorelin?
PT-141 is primarily a hormonal peptide, while Tesamorelin is used for performance & growth. PT-141 is FDA-approved for one or more indications, whereas Tesamorelin is FDA-approved for one or more indications.
What is PT-141 used for?
Sexual function peptide.
What is Tesamorelin used for?
GHRH for visceral fat.
Can you take PT-141 and Tesamorelin together?
Some users combine peptides within a single protocol, but stacking PT-141 and Tesamorelin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is PT-141 or Tesamorelin FDA-approved?
PT-141 is FDA-approved for one or more indications. Tesamorelin is FDA-approved for one or more indications.

Read the full articles

  • PT-141 — full monograph: mechanism, research, dosing & references
  • Tesamorelin — full monograph: mechanism, research, dosing & references

More Hormonal comparisons

PT-141 compared across categories

← All peptide comparisons